deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01874678

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

Sponsor: TTY Biopharm

Conditions Non-small-cell Lung Cancer (NSCLC)
Interventions TS-1/Cisplatin
Updated 6 times since 2017 Last updated: Jan 10, 2016 Started: Mar 31, 2011 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01874678, this NA trial focuses on Non-small-cell Lung Cancer (NSCLC) and remains completed. Sponsored by TTY Biopharm, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • TTY Biopharm
Data source: TTY Biopharm

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations